WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Trump promotes new drug price deal with Regeneron - UPI.com

On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new price policy push.

Raccontata dacnbc.comupi.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
upi.comStai leggendo2 mesi fa

Trump promotes new drug price deal with Regeneron - UPI.com

On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new price policy push.

originale
usatoday.com2 mesi fa

Trump touts drug pricing pact with Regeneron aimed at lowering costs

Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump administration.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 23 aprile 2026·cnbc.com

    Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

    Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

  2. venerdì 24 aprile 2026·upi.com

    Trump promotes new drug price deal with Regeneron - UPI.com

    On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new price policy push.

cnbc.com2 mesi fa

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

Leggi questa versione → originale